Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma
CONCLUSIONS: The impact of the COVID-19 pandemic on liver cancer care resulted in significant decreases and delays in repeated TACE treatments in 2020 compared to 2019. However, treatment delays did not seem to significantly impact survival.PMID:37090102 | PMC:PMC10121341 | DOI:10.1155/2023/8114732
Source: Canadian Journal of Gastroenterology - Category: Gastroenterology Authors: Kittipitch Bannangkoon Keerati Hongsakul Teeravut Tubtawee Phurich Janjindamai Source Type: research
More News: Canada Health | Cancer | Cancer & Oncology | Carcinoma | COVID-19 | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Pandemics | Study | Urology & Nephrology